-
1
-
-
0029031844
-
The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome [see comments]
-
Zietman A.L., Coen J.J., Dallow K.C., et al. The treatment of prostate cancer by conventional radiation therapy An analysis of long-term outcome [see comments]. Int J Radiat Oncol Biol Phys. 32:1995;287-292
-
(1995)
Int J Radiat Oncol Biol Phys
, vol.32
, pp. 287-292
-
-
Zietman, A.L.1
Coen, J.J.2
Dallow, K.C.3
-
2
-
-
0034554795
-
Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer
-
Pollack A., Zagars G.K., Smith L.G., et al. Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:2000;3904-3911
-
(2000)
J Clin Oncol
, vol.18
, pp. 3904-3911
-
-
Pollack, A.1
Zagars, G.K.2
Smith, L.G.3
-
3
-
-
0142155569
-
Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995
-
Thames H, Kuban D, Levy L, et al. Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995. Int J Radiat Oncol Biol Phys 2003;57:929-943
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 929-943
-
-
Thames, H.1
Kuban, D.2
Levy, L.3
-
4
-
-
0141498512
-
Can biochemical failure (ASTRO definition) be used as a surrogate endpoint for prostate cancer survival in phase III localized prostate cancer clinical trials? Analysis of RTOG protocol 92-02 [Abstract]
-
Sandler H., Pajak T., Hanks G., et al. Can biochemical failure (ASTRO definition) be used as a surrogate endpoint for prostate cancer survival in phase III localized prostate cancer clinical trials? Analysis of RTOG protocol 92-02 [Abstract]. Proc Am Soc Clin Oncol. 22:2003;381
-
(2003)
Proc Am Soc Clin Oncol
, vol.22
, pp. 381
-
-
Sandler, H.1
Pajak, T.2
Hanks, G.3
-
5
-
-
0036890728
-
Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy: A secondary analysis of the randomized protocol RTOG 86-10
-
Shipley W.U., Lu J.D., Pilepich M.V., et al. Effect of a short course of neoadjuvant hormonal therapy on the response to subsequent androgen suppression in prostate cancer patients with relapse after radiotherapy A secondary analysis of the randomized protocol RTOG 86-10. Int J Radiat Oncol Biol Phys. 54:2002;1302-1310
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 1302-1310
-
-
Shipley, W.U.1
Lu, J.D.2
Pilepich, M.V.3
-
6
-
-
0033526309
-
Natural history of progression after PSA elevation following radical prostatectomy
-
Pound C.R., Partin A.W., Eisenberger M.A., et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 281:1999;1591-1597
-
(1999)
JAMA
, vol.281
, pp. 1591-1597
-
-
Pound, C.R.1
Partin, A.W.2
Eisenberger, M.A.3
-
7
-
-
0038205813
-
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
-
D'Amico A.V., Moul J., Carroll P.R., et al. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. J Clin Oncol. 21:2003;2163-2172
-
(2003)
J Clin Oncol
, vol.21
, pp. 2163-2172
-
-
D'Amico, A.V.1
Moul, J.2
Carroll, P.R.3
-
8
-
-
0031403675
-
Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group
-
Medical Research Council and Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer Initial results of the Medical Research Council Trial. The Medical Research Council Prostate Cancer Working Party Investigators Group. Br J Urol. 79:1997;235-246
-
(1997)
Br J Urol
, vol.79
, pp. 235-246
-
-
-
9
-
-
0036499051
-
Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era
-
Kupelian P.A., Buchsbaum J.C., Patel C., et al. Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. Int J Radiat Oncol Biol Phys. 52:2002;704-711
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.52
, pp. 704-711
-
-
Kupelian, P.A.1
Buchsbaum, J.C.2
Patel, C.3
-
10
-
-
0035433469
-
Controversies in prostate cancer radiotherapy: Consensus development
-
Lukka H., Warde P., Pickles T., et al. Controversies in prostate cancer radiotherapy Consensus development. Can J Urol. 8:2001;1314-1322
-
(2001)
Can J Urol
, vol.8
, pp. 1314-1322
-
-
Lukka, H.1
Warde, P.2
Pickles, T.3
-
11
-
-
0038611532
-
-
BC Cancer Agency, Cancer Management Manual. http://www.bccancer.bc.ca/ HPI/CancerManagementGuidelines/Genitourinary/Prostate/Management/HighRisk.htm. Last accessed Nov 2003
-
Cancer Management Manual
-
-
-
12
-
-
0032972961
-
PSA relapse definitions - The Vancouver Rules show superior predictive power
-
Pickles T., Duncan G.G., Kim-Sing C., et al. PSA relapse definitions - the Vancouver Rules show superior predictive power. Int J Radiat Oncol Biol Phys. 43:1999;699-700
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.43
, pp. 699-700
-
-
Pickles, T.1
Duncan, G.G.2
Kim-Sing, C.3
-
13
-
-
0041879750
-
PSA doubling time post-radiation: The effect of prolonged neoadjuvant androgen ablation [Abstract]
-
Pickles T., Tyldesley S. Initiative PCO. PSA doubling time post-radiation The effect of prolonged neoadjuvant androgen ablation [Abstract]. Canad J Urol. 9:2002;1542
-
(2002)
Canad J Urol
, vol.9
, pp. 1542
-
-
Pickles, T.1
Tyldesley, S.2
-
14
-
-
0031984894
-
Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma
-
McLaren D.B., McKenzie M., Duncan G., et al. Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma. Cancer. 82:1998;342-348
-
(1998)
Cancer
, vol.82
, pp. 342-348
-
-
McLaren, D.B.1
McKenzie, M.2
Duncan, G.3
-
15
-
-
0037443507
-
What to do for prostate cancer patients with a rising PSA? - A survey of Australian practice
-
Duchesne G.M., Millar J.L., Moraga V., et al. What to do for prostate cancer patients with a rising PSA? - A survey of Australian practice. Int J Radiat Oncol Biol Phys. 55:2003;986-991
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.55
, pp. 986-991
-
-
Duchesne, G.M.1
Millar, J.L.2
Moraga, V.3
-
16
-
-
0034904071
-
The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy: A survey of practice patterns of urologists and radiation oncologists in the United States
-
Sylvester J., Grimm P., Blasco J., et al. The role of androgen ablation in patients with biochemical or local failure after definitive radiation therapy A survey of practice patterns of urologists and radiation oncologists in the United States. Urology. 58:(2 Suppl. 1):2001;65-70
-
(2001)
Urology
, vol.58
, Issue.2 SUPPL. 1
, pp. 65-70
-
-
Sylvester, J.1
Grimm, P.2
Blasco, J.3
-
17
-
-
0036890720
-
In regard to Kupelian et al.: Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. IJROBP 2002;52:704-711
-
Kwan W., Pickles T. In regard to Kupelian et al.: Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era. IJROBP 2002;52:704-711. Int J Radiat Oncol Biol Phys. 54:2002;1577-1579
-
(2002)
Int J Radiat Oncol Biol Phys
, vol.54
, pp. 1577-1579
-
-
Kwan, W.1
Pickles, T.2
-
18
-
-
0041564148
-
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy
-
Pollack A., Hanlon A.L., Movsas B., et al. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 57:2003;19-23
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.57
, pp. 19-23
-
-
Pollack, A.1
Hanlon, A.L.2
Movsas, B.3
-
19
-
-
0036893913
-
"pSA-itis:": Knowledge of serum prostate specific antigen and other causes of anxiety in men with metastatic prostate cancer
-
Lofters A., Juffs H.G., Pond G.R., et al. "PSA-itis:" Knowledge of serum prostate specific antigen and other causes of anxiety in men with metastatic prostate cancer. J Urol. 168:2002;2516-2520
-
(2002)
J Urol
, vol.168
, pp. 2516-2520
-
-
Lofters, A.1
Juffs, H.G.2
Pond, G.R.3
-
21
-
-
0016630067
-
The Veterans Administration Cooperative Urological Research Group studies of carcinoma of the prostate: A review
-
Blackard C.E. The Veterans Administration Cooperative Urological Research Group studies of carcinoma of the prostate: A review. Cancer Chemother Rep. 59:1975;225-227
-
(1975)
Cancer Chemother Rep
, vol.59
, pp. 225-227
-
-
Blackard, C.E.1
-
22
-
-
0034932358
-
A structured debate: Immediate versus deferred androgen suppression in prostate cancer - Evidence for deferred treatment [comment]
-
Walsh P.C., DeWeese T.L., Eisenberger M.A. A structured debate Immediate versus deferred androgen suppression in prostate cancer - evidence for deferred treatment [comment]. J Urol. 166:2001;508-515
-
(2001)
J Urol
, vol.166
, pp. 508-515
-
-
Walsh, P.C.1
Deweese, T.L.2
Eisenberger, M.A.3
-
23
-
-
0000945088
-
Immediate vs. deferred hormone treatment for prostate cancer: How safe is androgen deprivation?
-
Kirk D. Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate vs. deferred hormone treatment for prostate cancer How safe is androgen deprivation? Br J Urol. 86:(Suppl.):2000;220
-
(2000)
Br J Urol
, vol.86
, Issue.SUPPL.
, pp. 220
-
-
Kirk, D.1
|